ESTA Establishment Labs Holdings Inc.

NASDAQ
$69.61

Establishment Labs Holdings Inc. (ESTA) is expected to report earnings on January 28, 2027, before the market open. The consensus earnings estimate is a loss of $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.3% since its last earnings release on October 29, 2026.

Establishment Labs Missed Consensus Estimates, Raises Guidance
Thursday, October 29, 2026 · 8:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 28
Thursday · 8:00 AM ET
Earnings Whisper
-
vs ($0.11)
Rev est $75.15M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $66.41

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. is a global medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.